A Provisional Biopharmaceutical Classification of the Top 200 Oral Drug Products in the United States, Great Britain, Spain, and Japan

Waiver of In Vivo Bioavailability and Bioequivalence Studies forImmediate-Release Solid Oral Dosage Forms Based on a BiopharmaceuticsClassification System; FDA Guidance for Industry; Federal Drug and Food Administration:  Rockville, MD, 2002.

Amidon G. L., 1995, Pharm. Res., 12, 420

Yu L. X., 2002, Pharm. Res., 19, 925

Blume H. H., 1999, Eur. J. Pharm. Sci., 9, 121, 10.1016/S0928-0987(99)00076-7

Polli J. E., 2004, J. Pharm. Sci., 93, 1381, 10.1002/jps.20064

Cheng C.-L., 2004, Eur. J. Pharm. Sci., 22, 304, 10.1016/0014-2999(73)90030-7

Kasim N. A., 2004, Mol. Pharm., 1, 96, 10.1021/mp034006h

Lindenberg M., 2004, Eur. J. Pharm. Biopharm., 58, 278, 10.1016/j.ejpb.2004.03.001

Oh D.-M., 1993, Pharm. Res., 10, 270

Sun D., 2002, Pharm. Res., 19, 1416

Winiwarter S., 1998, J. Med. Chem., 41, 4949, 10.1021/jm9810102

Winiwarter S., 2003, J. Mol. Graphics Modell., 21, 287, 10.1016/S1093-3263(02)00163-8

Wu C.-Y., 2005, Pharm. Res., 22, 23

Electronic Orange Book, 2005, Approved Drug Products with Therapeutic Equivalence Evaluations, 24

Japanese Orange Book, 2005, http://www.jp-orangebook.gr.jp/ (accessed

Medicines.org.uk., provided by Datapharm Communications Ltd.http://www.medicines.org.uk/(accessed July 2005).

The database maintained by the Spanish Professional Pharmacists Association (Spanish only)., 2005, http://www.portalfarma.com/home.nsf (accessed

The information provided by the Spanish Agency of Medicines (Spanish only)., 2005, http://www.agemed.es/Index.htm (accessed

2005, WHO List of Essential Drugs, 14

2001, The Merck Index, 13

Volume I, 2004, Drug Information for the Health Care Professional, 24

Volume III, 2004, Approved Drug Products and Legal Requirements, 24

Prescription information for Japanese drugs provided by Pharmaceuticals and Medical Device Agency (Japanese only)http://www.info.pmda.go.jp/(accessed July 2005).

EMEA, 2001, July

Guidelines, 2006, http://www.nihs.go.jp/drug/be-guide(e)/Generic/be97E.pdf (accessed

Ghose A. K., 1987, J. Chem. Inf. Comput. Sci., 27, 35, 10.1021/ci00053a005

Leo A. J, 1993, Chem. Rev., 93, 1306

Regårdh C. G., 1974, J. Pharamcokinet. Biopharm., 2, 364

Machatha S., 2005, Int. J. Pharm., 294, 192, 10.1016/j.ijpharm.2005.01.023

Bodemar G., 1981, Clin. Pharmacokinet., 6, 315, 10.2165/00003088-198106040-00005

Guay D. R., 1983, Clin. Pharm., 2, 162

Chau N. P., 1982, Clin. Pharmacol. Ther., 31, 774

Garg D. C., 1983, Clin. Pharmacol. Ther., 33, 452

van Hecken A. M., 1982, Br. J. Clin. Pharmacol., 14, 200, 10.1111/j.1365-2125.1982.tb01961.x

McNeil J. J., 1981, Br. J. Clin. Pharmacol., 12, 415, 10.1111/j.1365-2125.1981.tb01236.x

Mason W. D., 1979, Clin. Pharmacol. Ther., 25, 415, 10.1002/cpt1979254408

Benet L. Z., 1996, Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9, 1792

Thummel K. E., 2001, Goodman and Gilman's The Pharmacological Basis of Therapeutics, 10, 2023

Duchin K. L., 1982, Clin. Pharmacol. Ther., 31, 458, 10.1038/clpt.1982.59

Hinderling P. H., 1991, Ther. Drug Monit., 13, 401, 10.1097/00007691-199109000-00001

Pade V., 1987, J. Pharm. Sci., 87, 1607

Klepser M. E., 1996, Pharmacotherapy, 16, 662, 10.1002/j.1875-9114.1996.tb03649.x

Yu L. X., 2001, Sept 13 and 14

Vogelpoel H., 2004, J. Pharm. Sci., 93, 1956, 10.1002/jps.20131

Kortejärvi H., 2005, J. Pharm. Sci., 94, 1625, 10.1002/jps.20392

Jantratid E., 2006, J. Pharm. Sci., 95, 984, 10.1002/jps.20614

Verbeeck R. K., 2005, J. Pharm. Sci., 94, 1395, 10.1002/jps.20343

Ganapathy M. E., 1995, J. Biol. Chem., 270, 25677, 10.1074/jbc.270.43.25672

Wright E. M., 2003, Best Pract. Res. Clin. Gastroenterol., 17, 956, 10.1016/S1521-6918(03)00107-0

Han H.-K., 1999, J. Pharm. Sci., 88, 50

Flanagan S. D., 1999, Pharm. Res., 16, 224, 10.1023/A:1018868123367

Kanai Y., 2003, J. Toxicol. Sci., 28, 17, 10.2131/jts.28.1

Soldner A., 2000, Br. J. Pharmacol., 129, 1243, 10.1038/sj.bjp.0703150

Han H.-K., 1998, Pharm. Res., 15, 1386